Sheridan, J., Coe, C. A., Doran, P., Egan, L., Cullen, G., Kevans, D., Leyden, J., Galligan, M., O'Toole, A., McCarthy, J., & Doherty, G. (2018). protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis) led by the INITIAtive group (NCT 0268772). BMJ open gastroenterology, 5(1), . http://access.bl.uk/ark:/81055/vdc_100135137688.0x000002